期刊文献+

奈达铂体外诱导人卵巢癌顺铂耐药细胞凋亡的机制 被引量:4

Nedaplatin Induced Apoptosis in Human Ovarian Cancer Cisplatin-resistant Cell Lines in vitro and Investigated Its Mechanism
暂未订购
导出
摘要 目的探讨研究奈达铂(NDP)体外对人卵巢癌顺铂原发耐药细胞株SKOV3和继发耐药株SK-OV3/DDP的抑制作用及其机制。方法采用MTT法检测体外不同时间不同浓度的NDP对SKOV3及SKOV3/DDP细胞的杀伤作用,计算半数抑制浓度(IC50);流式细胞术(FCM)测定给药前后细胞凋亡率及周期分布变化;半定量PCR分析凋亡基因Bcl-2,Bax,caspase-3,caspase-9及反应肿瘤细胞侵袭力的基因MMP-2的表达变化。结果 NDP能明显抑制SKOV3及SKOV3/DDP生长,呈时间-剂量依赖性;流式结果显示随时间、浓度增加,SKOV3和SKOV3/DDP细胞凋亡明显增加,S期细胞的比例增加,差异均有统计学意义(P<0.05)。与对照组相比,Bcl-2、MMP-2表达减少,Bax,caspase-3,caspase-9表达增加。结论 NDP可抑制SKOV3和SKOV3/DDP细胞增殖,其机制可能与诱导细胞凋亡,细胞S期阻滞,下调Bcl-2及上调Bax,caspase-3,caspase-9的表达有关;同时可下调MMP-2的表达,有利于降低卵巢癌细胞的侵袭力。 Objective To study inhibition of nedaplatin(NDP) on human ovarian cancer cell lines SKOV3 with intrinsic cisplatin-resistance and SKOV3/DDP with acquired cisplatin-resistance and investigate its mechanism. Methods MTT assay was used to evaluate the inhibition in different concentration and time of NDP treatment on SKOV3 and SKOV3/DDP cells,then calculated inhibitory concentration( IC50 ). Cell apoptosis and cycle were detected by flow cytometry (FCM). The changes of Bcl- 2, Bax, caspase-3, caspase-9,MMP-2 in mRNA levels were quantified by RT-PCR. Results NDP inhibited the growth of SKOV3 and SKOV3/DDP cells significantly in time and dose-dependent manner. The result from FCM showed that apoptotic rate and the percentage of S-phase cells tend to increase in time and concentration of nedaplatin dependent manner(P〈0.05). Compared with control groups,there were a decrease in Bcl 2 and MMP-2 mRNA expression,but an increase in Bax,caspase-3 and caspase-9. Conclusion NDP can in hibit proliferation of SKOV3 and SKOV3/DDP cells. The effect may be ascribed to inducing cell apoptosis, the S-phase arrest and the down regulation of Bcl- 2, MMP-2 expression, up-regulation of Bax, caspase- 3 and caspase-9 expression. NDP can suppress MMP 2 expression,so it maybe can reduce invasion force of ovarian cancer.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2012年第10期1216-1220,共5页 Cancer Research on Prevention and Treatment
基金 广西自然科学基金资助项目(0832136) 广西壮族自治区卫生厅资助课题(S200803)
关键词 奈达铂 SKOV3 SKOV3/DDP 细胞凋亡 顺铂耐药 Nedaplatin SKOV3 SKOV3/DDP Cell apoptosis Cisplatin resistance
  • 相关文献

参考文献11

  • 1Aletti GD,Gallenberg MM, Cliby WA, et al. Current manage- ment strategies for ovarian cancer [J]. Mayo Clin Proc,2007, 82(6) :751-70.
  • 2Bhoola S, Hoskins WJ. Diagnosis and management of epithelialovarian cancer[J]. Obstet Gynecol,2006,107(6) :1399-410.
  • 3徐瑞华,管忠震,姜文奇,黄河,胡晓桦,谢伟敏,李星庚,刘亚利,潘良熹,戴爱娣,庄武,张春,马智勇,王建华.奈达铂治疗非小细胞肺癌的Ⅱ期临床研究报告[J].癌症,2002,21(12):1354-1358. 被引量:132
  • 4Freeburg EM, Goyeneche AA, Seidel EE, et al. Resistance to cisplatin does not affect sensitivity of human ovarian cancer cell lines to mifepristone cytotoxieity [J]. Cancer Cell Int, 2009, 9:4.
  • 5Monk BJ, Alberts DS, Burger RA, et aL In vitro phase II com- parison of the cytotoxicity of a novel platinum analog, nedapla- tin (254-S), with that of cisplatin and carboplatin against fresh, human cervical cancers[J]. Gynecol Oncol, 1998,71 (2) : 308-12.
  • 6Koshiyama M,Kinezaki M, Uchida T, et al. Chemosensitivity testing of a novel platinum analog, nedaplatin (254-S), in hu- man gynecological carcinomas: a comparison with cisplatin[J]. Anticancer Res,2005,25(6C) :4499-502.
  • 7孙正怡,沈铿,许秀英,郎景和.羟基喜树碱和topotecan对人卵巢癌细胞株体外作用的研究[J].中华妇产科杂志,1999,34(9):547-550. 被引量:6
  • 8郭爱平,李苏宜.重组人生长激素联合奈达铂在体外对人食管癌细胞株EC109作用的实验研究[J].现代医学,2007,35(5):370-374. 被引量:6
  • 9谈华阳,苏翔宇,李苏宜.奈达铂联合顺铂体外干预人卵巢癌Skov-3细胞生长的实验研究[J].临床肿瘤学杂志,2009,14(4):301-305. 被引量:5
  • 10Tanaka R,Takii Y, Shibata Y, et al. In vitro sequence-depend eat interaction between nedaplatin and paclitaxel in human cancer cell lines [J]. Cancer Chemother Pharmacol, 2005, 56 (3) :279-85.

二级参考文献25

  • 1Mark F van Delft,David CS Huang.How the Bcl-2 family of proteins interact to regulate apoptosis[J].Cell Research,2006,16(2):203-213. 被引量:39
  • 2Hattmann JT, Lipp HP. Toxicity of platinum compounds [J].Expert Opin Pharmacother, 2003,4 ( 6 ) : 889 - 901.
  • 3Heike Y,Takahashi M,Ohira T,et al. In vivo screening models of cisplatin-resistant human lung cancer cell lines using SCID mice [ J ]. Cancer Chemother Phamacol, 1995,35 ( 3 ) :200 - 204.
  • 4Nishida M, Satoh Y, Nishide K,et al. Phase Ⅰ study of a combination chemotherapy of nedaplatin and cisplatin[J]. Gan To Kagaku Ryoho, 1999,26 ( 14 ) :2209 - 2215.
  • 5[1]Harrison L E,Brennan M F.The role of total parenteral nutrition in the patient with cancer[J].Current Problems in Surgery,1995,32(10):837-840.
  • 6[3]Snibson K J,Bhathal P S,Adams T E.Overexpressed growth hormone(GH) synergistically promotes carcinogen-initiated liver tumour growth by promoting cellular proliferation in emerging hepatocellular neoplasms in female and male GH-transgenic mice[J].Liver,2001,21(2):149-158.
  • 7[4]Ergun-Longmire B,Mertens A C,Mitby P,et al.Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor[J].J Clin Endocrinol Metab,2006,91(9):3494-3498.
  • 8[5]Fiebig H H,Dengler W,Hendriks H R,et al.No evidence of tumor growth stimulation in human tumors in vitro following treatment with recombinant human growth hormone[J].Anti-cancer Drug,2000,11(8):659-664.
  • 9[7]Solar C A,Mertens A C,Mitby P,et al.Risk of disease recurrence and second neoplasms in survivors of childhood cancer treatment with growth hormone:a report from the childhood cancer survivors study[J].J Clin Endocrinol Metab,2002,87(7):3136-3141.
  • 10[8]Tacke J,Bolder U,Herrmann A,et al.Long-term risk of gastro-intestinal tumor recurrence after postoperative treatment with recombinant human growth hormone[J].J Parenteral Enteral Nutr,2000,24(3):140-144.

共引文献151

同被引文献37

  • 1王莉,刘汉锋,蔡正文,罗婕.奈达铂体外诱导肺腺癌A549细胞凋亡及其作用机制[J].西安交通大学学报(医学版),2012,33(3):332-335. 被引量:3
  • 2彭杰文,梁汉霖,肖剑军,张朝珍.多西紫杉醇联合奈达铂治疗晚期宫颈癌的疗效观察[J].中国肿瘤临床与康复,2006,13(2):114-116. 被引量:17
  • 3符淳,李光仪,刘晓英,林秋华,刘风英,谢咏.顺铂诱导卵巢癌耐药细胞系A2780/DDP凋亡的时间和剂量依从性[J].肿瘤防治研究,2006,33(8):561-564. 被引量:9
  • 4王华,王秀美,叶丽华,贡丽霞,韦溶澄.多西紫杉醇联合奈达铂治疗复发卵巢上皮癌临床研究[J].山东医药,2007,47(13):62-62. 被引量:6
  • 5Tsuda H, Hashiguchi Y, Nishimura S, et al. Phase I - II study of irinotecan ( CPT - 1] ) plus nedaplatin ( 254 - S) with recombinant human granulocyte colony - stimulating factor support in patients with advanced or recurrent cervical cancer [J] . Br J Cancer, 2004, 91 (6) : 1032.
  • 6Brigitte MT, Hougardya, Ate GJ, et al. Sens- itivity to Fas - mediated apoptosis in high - risk HPV - positive human cervical cancer cells: Relationship with Fas, caspase - 8, and Bid [ J] . Gynecologic Oncology, 2005, 97 (2): 353.
  • 7Yuh -Cheng Yang KS, Clifford Chao, Chin -Ping Lin, et al. Oxaliplatin regulates DNA repair responding to ionizing ra- diation and enhances radiosensitivity of human cervical cancer cells [ J] . International Journal of Gynecological Cancer, 2009, 19 (4): 782.
  • 8Funaoka K, Shindoh M, Yamashita T, et al. High - risk HPV -positive human cancer cell lines show different sensitivity to cisplatin - induced apoptosis correlated with the p21Wafl/Cipl level [J] . Cancer Lett, 1996, 108 (1): 15.
  • 9Risa Tanaka, Yasushi Takii, Yoshihiro Shibata. In vitro se- quence - dependent interaction between nedaplatin and paclita- xel in human cancer cell lines [ J] . Cancer Chemother Phar-macol, 2005, 56 (3): 279.
  • 10Bratton SB, Mac Farlane M, Cain K, et al. Protein complexes activate distinct caspase cascades in death receptor and stress- induced apoptosis [ J] . Exp Cell Res, 2000, 256 (1): 27.

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部